FDA Embraces AI to Expedite Drug Reviews
The U.S. Food and Drug Administration (FDA) is rapidly integrating AI into its regulatory processes, aiming to enhance efficiency and reduce review times across all centers.
Follow the subjects shaping intelligence, science, culture, and the future of technology.
Find a subject, then follow its latest reporting and ideas.
Stories, interviews, and analysis in this subject.